Evidence map›Paper›PMID 37581106›Full record

ArticleBMJ oncology2023

Community-generated solutions to cancer inequity: recommendations from transgender, non-binary and intersex people on improving cancer screening and care.

Sachiko Ragosta, Jasmine Berry, Moria Mahanaimy, Laura Fix, Anu Manchikanti Gomez, Juno Obedin-Maliver, Heidi Moseson

Open access · diamondAbstract read
In one paragraph

Article in BMJ oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sachiko RagostaIbis Reproductive Health, Oakland, California, USA.ORCID 0000-0002-2776-0638
Jasmine BerryIbis Reproductive Health, Oakland, California, USA.
Moria MahanaimyIbis Reproductive Health, Oakland, California, USA.
Laura FixIbis Reproductive Health, Oakland, California, USA.
Anu Manchikanti GomezSchool of Social Welfare, University of California, Berkeley, California, USA.
Juno Obedin-MaliverDepartment of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California, USA.
Heidi MosesonIbis Reproductive Health, Oakland, California, USA.ORCID 0000-0002-2488-2429
Ibis Reproductive Health · USStanford University · USUniversity of California, Berkeley · US

Funding

Toward an improved screening protocol: developing and testing an organ inventory for strengthening clinical care and researchR21CA256759 · NCI · IBIS REPRODUCTIVE HEALTH · PI MOSESON LIDOW, HEIDI SERENE · 2020 to 2021
$317k
NCI NIH HHS R21 CA256759
6 · The paper itself

Abstract

Objective: Transgender, non-binary and intersex people are less likely to receive appropriate cancer screening for their bodies and have a higher incidence of certain cancers than cisgender people. We aimed to elicit community-generated solutions to improve cancer screening for these populations. Methods and analysis: We conducted six online, asynchronous focus groups in English and Spanish with transgender, non-binary, intersex and cisgender participants who were at least 15 years of age from across the USA. Participants shared their experiences with cancer screening and related conversations with healthcare providers and recommendations for making screening practices more inclusive of their bodies and experiences. Focus group data were exported into transcripts and analysed with thematic analysis. Results: The 23 participants represented a diversity of races, genders, sexualities, ages and geographical locations. Transgender, non-binary and intersex participants, particularly Black, Indigenous and/or people of colour, reported having to self-advocate to receive necessary care by initiating conversations about screening with their providers, requesting specific screenings and educating providers about the appropriate care for their body. Notably, no white or cisgender participants described having to request relevant screenings or initiate conversations with their providers. Participants recommended that forms ask about body parts and allow for self-identification. Conclusion: The ability to properly screen patients can have a direct impact on cancer outcomes. More inclusive intake forms may alleviate the need for transgender, non-binary and intersex patients to self-advocate to receive necessary care. More work should be done to educate providers on cancer risk for transgender, non-binary and intersex individuals.

Identifiers

PMID37581106
PMCPMC10424502
OpenAlexW4380591279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.